LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | AZD8055 | 0.04 | uM | LJP6 | 3 | A12 | 72 | hr | 1389 | 1466 | 5740 | 0.2554 | 0.0267 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 1 | A11 | 72 | hr | 1389 | 1149 | 5147 | 0.2232 | -0.0955 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 2 | A11 | 72 | hr | 1389 | 1564 | 5447 | 0.2871 | 0.0620 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 3 | A11 | 72 | hr | 1389 | 1485 | 5740 | 0.2587 | 0.0332 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 1 | A10 | 72 | hr | 1389 | 1177 | 5147 | 0.2287 | -0.0839 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 2 | A10 | 72 | hr | 1389 | 1599 | 5447 | 0.2935 | 0.0740 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 3 | A10 | 72 | hr | 1389 | 1578 | 5740 | 0.2749 | 0.0643 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 1 | A09 | 72 | hr | 1389 | 1195 | 5147 | 0.2322 | -0.0765 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 2 | A09 | 72 | hr | 1389 | 1633 | 5447 | 0.2998 | 0.0855 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 3 | A09 | 72 | hr | 1389 | 1705 | 5740 | 0.2970 | 0.1053 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 1 | A08 | 72 | hr | 1389 | 1261 | 5147 | 0.2450 | -0.0499 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 2 | A08 | 72 | hr | 1389 | 1403 | 5447 | 0.2575 | 0.0051 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 3 | A08 | 72 | hr | 1389 | 1575 | 5740 | 0.2744 | 0.0633 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 1 | A07 | 72 | hr | 1389 | 895 | 5147 | 0.1739 | -0.2075 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 2 | A07 | 72 | hr | 1389 | 1281 | 5447 | 0.2351 | -0.0402 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 1389 | 1185 | 5740 | 0.2064 | -0.0747 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 1389 | 4484 | 5147 | 0.8712 | 0.8592 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 2 | B12 | 72 | hr | 1389 | 5724 | 5447 | 1.0507 | 1.0508 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 1389 | 5350 | 5740 | 0.9320 | 0.9323 |
| MCF7 | Sorafenib | 0.12 | uM | LJP6 | 1 | B11 | 72 | hr | 1389 | 4379 | 5147 | 0.8508 | 0.8361 |
| MCF7 | Sorafenib | 0.12 | uM | LJP6 | 2 | B11 | 72 | hr | 1389 | 5326 | 5447 | 0.9776 | 0.9772 |
| MCF7 | Sorafenib | 0.12 | uM | LJP6 | 3 | B11 | 72 | hr | 1389 | 5256 | 5740 | 0.9156 | 0.9157 |
| MCF7 | Sorafenib | 0.37 | uM | LJP6 | 1 | B10 | 72 | hr | 1389 | 4556 | 5147 | 0.8852 | 0.8750 |
| MCF7 | Sorafenib | 0.37 | uM | LJP6 | 2 | B10 | 72 | hr | 1389 | 5346 | 5447 | 0.9813 | 0.9809 |
| MCF7 | Sorafenib | 0.37 | uM | LJP6 | 3 | B10 | 72 | hr | 1389 | 4936 | 5740 | 0.8599 | 0.8578 |